期刊
ACS SENSORS
卷 2, 期 6, 页码 718-723出版社
AMER CHEMICAL SOC
DOI: 10.1021/acssensors.7b00176
关键词
biosensors; point-of-care; DNA nanotechnology; whole blood; therapeutic drug monitoring
资金
- NSERC discovery grant [RGPIN-2014-06403]
- European Research Council (ERC) [336493]
- EU-IRSES grant Chimera
The development of a universal sensing mechanism for the rapid and quantitative detection of small molecules directly in whole blood would drastically impact global health by enabling disease diagnostics, monitoring, and treatment at home. We have previously shown that hybridization between a free DNA strand and its complementary surface-bound strand can be sterically hindered when the former is bound to large antibodies. Here, we exploit this effect to design a competitive antibody-based electrochemical assay, called CeSHHA, that enables the quantitative detection of small molecules directly in complex matrices, such as whole blood or soil. We discuss the importance of this inexpensive assay for point-of-care diagnosis and for treatment monitoring applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据